Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

Sponsors

Lead Sponsor: Kessler Foundation

Collaborator: Kessler Institute for Rehabilitation

Source Kessler Foundation
Brief Summary

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Overall Status Recruiting
Start Date 2017-10-05
Completion Date 2021-12-30
Primary Completion Date 2021-12-30
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Distance walked in a specific time duration approximately 12 weeks
Neuropsychological measures of thinking approximately 12 weeks
Brain scans approximately 12 weeks
Enrollment 10
Condition
Intervention

Intervention Type: Device

Intervention Name: Robotic Exoskeleton Rehabilitation

Description: Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Arm Group Label: Robotic Exoskeleton Therapy

Intervention Type: Other

Intervention Name: Conventional Gait Therapy

Description: Participants will be randomly assigned to one of the two groups. Each participant will receive 8 sessions of gait rehabilitation and therapy via traditional therapy techniques of using the robotic exoskeleton. This training will be provided by a licensed physical therapist.

Arm Group Label: Conventional Gait Therapy

Eligibility

Criteria:

Inclusion Criteria: - Be diagnosed with multiple sclerosis. - Be determined by the study staff to have moderate to severe difficulty walking but still be able to walk while using the robotic exoskeleton. - Have some difficulty thinking and problem solving as determined by my performance on a special test that I will take during the screening visit. - Be between the ages of 18 and 75. - Be free from flair ups of my MS Symptoms for at least one month prior to testing. - Discuss with study staff how to maintain a constant level of my spasticity medication (for example baclofen) throughout the study. - Be able to walk (with the use of one or more assistive device if needed). - Have English as my primary language. - Be able to physically fit into the exoskeleton device: height between 60 and 76", weight under 220 lbs. - Be able to tolerate upright standing for 30 minutes with assistance if needed. - Have normal joint range of motion for walking as determined by study staff. - Have sufficient strength to use the hemiwalker, bilateral canes or walker while wearing the RE. - Have stable blood pressure. - Be willing and able to give informed consent. - Be able and willing to comply with study procedures and follow directions and commands, verbal instructions, and follow-up requirements. Exclusion Criteria: - Have a history of head injury, stroke, seizures, or any other significant neurological history other than MS. - Have a high degree of difficulty in thinking and problem solving that prevents me from participating in the study as determined by my performance on a special test taken during the screening visit. - Be currently taking steroids, benzodiazepines, antipsychotics, and/or neuroleptics as determined by study staff review of my medications. - Be pregnant. - Be completely reliant on a wheelchair. - Have joint contracture or spasticity of any limb that limits normal range of motion during walking with assistive devices as determined by study staff. - Have skin issues that would prevent wearing the RE. - Have pressure sore stage 2 or higher located in an area that would negatively affect weight bearing, harness fit, or therapist assistance. - Have orthopedic issues or history that will interfere with walking or limit the range of motion of the lower limbs (e.g., knee replacement, inflammation) - Have been hospitalized for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study. - Have any other medical conditions that my doctor or physical therapist feels would affect my ability to use the robotic device. - Have a pacemaker or other implanted electrical device, brain stimulator, aneurysm clip (metal clips on the wall of a large artery), metallic prostheses (including metal pins and rods, heart valves, and internal hearing aids [cochlear implants]), permanent eyeliner, implanted delivery pumps, or shrapnel fragments. - Have dental implants- I should discuss any dental implants with the investigators. - Have been told by my doctor that it is unsafe for me to have a regular MRI as part of my medical care.

Gender:

All

Minimum Age:

18 Years

Maximum Age:

75 Years

Healthy Volunteers:

No

Location
Facility: Status: Contact: Kessler Foundation Ghaith J Androwis, Ph.D. 973-324-3565 [email protected]
Location Countries

United States

Verification Date

2021-04-01

Responsible Party

Type: Sponsor

Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Label: Robotic Exoskeleton Therapy

Type: Experimental

Description: Gait rehabilitation provided using a wearable robotic exoskeleton

Label: Conventional Gait Therapy

Type: Active Comparator

Description: Gait rehabilitation provided using traditional gait therapy under the supervision of a licensed PT

Patient Data Undecided
Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Primary Purpose: Treatment

Masking: Single (Participant)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Research News